Colon-Specific Drug Delivery Based on a Cyclodextrin Prodrug: Release Behavior of Biphenylylacetic Acid from Its Cyclodextrin Conjugates in Rat Intestinal Tracts after Oral Administration

Friend, 1992 Rubinstein, 1995, Approaches and opportunities in colon-specific drug delivery, CRC Crit. Rev. Ther. Drug Carrier Syst, 12, 101, 10.1615/CritRevTherDrugCarrierSyst.v12.i2-3.10 Peeters, 1993, Film-forming polymers for colonic drug delivery: I. synthesis and physical and chemical properties of methyl derivatives of eudragit, S. Int. J. Pharm, 94, 125, 10.1016/0378-5173(93)90016-9 Takaya, 1995, Development of a colon delivery capsule and the pharmacological activity of recombinant human granulocyte colony- stimulating factor (rhG-CSF) in beagle dogs, J. Pharm. Pharmacol., 47, 474, 10.1111/j.2042-7158.1995.tb05834.x Gazzaniga, 1995, Time-dependent oral delivery systems for colon targeting, S.T.P. Pharma Sci., 5, 83 Saffran, 1986, A new approach to the oral administration of insulin and other peptide drugs, Science, 233, 1081, 10.1126/science.3526553 Larsen, 1989, Macro- molecular prodrugs. XVI. Colon-targeted delivery-comparison of the rate of release of naproxen from dextran ester prodrugs in homogenates of various segments of the pig gastrointestinal (GI) tract, Pharm. Res., 6, 995, 10.1023/A:1015914101233 Kopeček, 1992, N-(2-Hydroxypropyl)methacryl- amide copolymers for colon-specific drug delivery, 189 Friend, 1992, Glycosides in colonic drug delivery, 153 Duchêne, 1991 Loftsson, 1991, 2-Hydroxypropyl- ß-cyclodextrin: properties and usage in pharmaceutical formulations, Pharm. Ztg. Wiss., 4, 5 Uekama, 1991, Irie, T. Pharmaceutical uses of cyclodextrin derivatives, 789 1996 Stella, 1997, Cyclodextrins: their future in drug formulation and delivery, Pharm. Res., 14, 556, 10.1023/A:1012136608249 Andersen, 1983, The utilization of schardinger dextrins by the rat, Toxicol. Appl. Pharmacol., 5, 257, 10.1016/0041-008X(63)90048-6 Antenucci, 1984, Enzymatic degradation of α- and β-cyclodextrins by bacteroids of the human colon, J. Agric. Food Chem., 32, 1316, 10.1021/jf00126a025 Gerlóczy, 1985, Absorption, distribution, excretion and metabolism of orally administered 14C-β-cyclodextrin in rat, Arzneim. Forsch./Drug Res., 35, 1042 Flourié, 1993, Fate of β-cyclodextrin in the human intestine, J. Nutr., 123, 676, 10.1093/jn/123.4.676 Hirayama, 1996, In vitro evalution of biphenylyl acetic acid-β-cyclodextrin conjugates as colontargeting prodrug: drug release behaviour in rat biological media, J. Pham. Pharmacol., 48, 27, 10.1111/j.2042-7158.1996.tb05871.x Uekama, 1997, 6A-O-[(4-Biphenylyl)- acetyl]-α-, -β- and -γ-cyclodextrins and 6A-deoxy-6A-[[(4- biphenylyl)acetyl]amino]-α-, -β- and -γ-cyclodextrins: potential prodrugs for colon-specific delivery, J. Med. Chem., 40, 2755, 10.1021/jm970130r Arima, 1990, Enhancement of the antiinflammatory effect of ethyl 4-bi- phenylylacetate in ointment by β-cyclodextrin derivatives: increased absorption and localized activation of the prodrugs in rats, Pharm. Res., 11, 1152, 10.1023/A:1015932325998 Ohnishi, 1992, Study of pharmcokinetics and safety of felbinac patch, Jpn. Pharm- col. Ter., 20, 115 Chiccarelli, 1980, Disposition and metabolism of fenbufen in several laboratory animals, Arzneim. Forsch./Drug Res., 30, 707 Nakamura, 1982, Antiinflammatony activity of a nonsteroidal anti-inflammatony agent, zomepirac sodium, in experimental animals, Folia Pharmacol. Jpn., 79, 509, 10.1254/fpj.79.509 Winter, 1962, Carrageenin-induced edema in hind paw of the rat as an assay for antiinflam- matony drugs, Proc. Soc. Exp. Bio. Med., 111, 544, 10.3181/00379727-111-27849 Simpkins, 1988, Evidence for the delivery of narcotic antagonists to the colon as their glucuronide conjugates, J. Pharmcol. Exp. Ther., 244, 195 McLeod, 1992, Kinetic perspectives in colonic drug delivery, 85 Matsuoka, 1980, 248 Hirayama, 1993, Inhibitory effect of guest molecules on acid-catalyzed ring-opining of β-cyclodextrin, J. Chem. Soc., Chem. Commun., 1578, 10.1039/C39930001578